Lv4
640 积分 2023-08-13 加入
Antitumour actions of interferons: implications for cancer therapy
16天前
已完结
Achievable but elusive: LLDAS and DORIS remission in clinical trials of belimumab
2个月前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
2个月前
已完结
Next generation of tumor-activating type I IFN enhances anti-tumor immune responses to overcome therapy resistance
2个月前
已完结
Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects
3个月前
已完结
Fit-for-Purpose Immunohistochemical Biomarkers
3个月前
已完结
Harnessing cytokines and chemokines for cancer therapy
3个月前
已完结
A single infusion of engineered long-lived and multifunctional T cells confers durable remission of asthma in mice
5个月前
已完结
Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis
5个月前
已完结
Engineered IFN-α and anti-PDL1 containing compounds to target the liver and restore antiviral protection for HBV cure
5个月前
已完结
皖公网安备34019202002308
